Industry Strength Score
54/100
Composite price performance score based on 3, 6, and 12-month returns, with more weight on recent trends.
SAREPTA THERAPEUTICS INC (1SRPT.MI) Stock Price & Overview
BIT:1SRPT • US8036071004
Current stock price
18.9 EUR
-0.68 (-3.47%)
Last:
The current stock price of 1SRPT.MI is 18.9 EUR. Today 1SRPT.MI is down by -3.47%. In the past month the price increased by 86.57%.
1SRPT.MI Key Statistics
1-Month Range14.315 - 20.51
Current 1SRPT.MI stock price positioned within its 1-month range.
- Market Cap
- 1.984B
- P/E
- N/A
- Fwd P/E
- 7.13
- EPS (TTM)
- -5.64
- Dividend Yield
- N/A
1SRPT.MI Stock Performance
Today
-3.47%
1 Week
+6.36%
1 Month
+86.57%
3 Months
N/A
Longer-term
6 Months N/A
1 Year N/A
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A
1SRPT.MI Stock Chart
1SRPT.MI Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to 1SRPT.MI.
Chartmill TA Rating
Chartmill Setup Rating
1SRPT.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to 1SRPT.MI. 1SRPT.MI has a bad profitability rating. Also its financial health evaluation is rather negative.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
1SRPT.MI Earnings
On February 25, 2026 1SRPT.MI reported an EPS of -3.93 and a revenue of 442.93M. The company missed EPS expectations (-213.05% surprise) and beat revenue expectations (10.8% surprise).
Next Earnings DateMay 6, 2026
Last Earnings DateFeb 25, 2026
PeriodQ4 / 2025
EPS Reported-$3.93
Revenue Reported442.934M
EPS Surprise -213.05%
Revenue Surprise 10.80%
1SRPT.MI Forecast & Estimates
33 analysts have analysed 1SRPT.MI and the average price target is 19.58 EUR. This implies a price increase of 3.61% is expected in the next year compared to the current price of 18.9.
For the next year, analysts expect an EPS growth of 147.03% and a revenue growth -18.84% for 1SRPT.MI
Analysts
Analysts68.48
Price Target19.58 (3.6%)
EPS Next Y147.03%
Revenue Next Year-18.84%
1SRPT.MI Financial Highlights
Over the last trailing twelve months 1SRPT.MI reported a non-GAAP Earnings per Share(EPS) of -5.64. The EPS decreased by -391.67% compared to the year before.
Income Statements
Revenue(TTM)2.20B
Net Income(TTM)-713.41M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -21.3% | ||
| ROE | -62.55% | ||
| Debt/Equity | 0.73 |
Chartmill High Growth Momentum
EPS Q2Q%-362%
Sales Q2Q%-32.73%
EPS 1Y (TTM)-391.67%
Revenue 1Y (TTM)15.58%
1SRPT.MI Ownership
Ownership
Inst Owners89.82%
Shares104.99M
Float99.57M
Ins Owners5.13%
Short Float %N/A
Short RatioN/A
1SRPT.MI Industry Overview
1SRPT.MI operates in the Biotechnology sub-industry within the Health Care sector. This group contains 412 stocks and is scored by ChartMill on both price strength and growth momentum.
Industry Growth Score
14/100
Composite growth score based on earnings growth, revenue growth, and profitability across the sub-industry.
Relative Performance
Each rank shows how many other sub-industries were outperformed over that timeframe.
1 Month Rank
27%
Outperformed 27% of sub-industries
3 Month Rank
49%
Outperformed 49% of sub-industries
6 Month Rank
29%
Outperformed 29% of sub-industries
Industry Fundamentals & Breadth
- Members
- 412
- New Highs
- 4.6%
- New Lows
- 4.6%
- Average ROE
- 47%
- Average Profit Margin
- 20.7%
- Average Operating Margin
- 33.9%
- Average P/E
- 22.9
- Average Fwd P/E
- 18.2
- Average Debt/Equity
- 2.1
1SRPT.MI Competitors/Peers
The largest stocks on the EU markets in the "Biotechnology" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ARGX | ARGENX SE | 28.81 | 41.543B | ||
| 1AE | ARGENX SE | 28.79 | 41.518B | ||
| 22UA | BIONTECH SE-ADR | N/A | 22.443B | ||
| ABVX | ABIVAX SA | N/A | 7.648B | ||
| 2X1 | ABIVAX SA | N/A | 7.64B | ||
| GLPG | GALAPAGOS NV | N/A | 1.591B | ||
| GXE | GALAPAGOS NV | N/A | 1.59B | ||
| NANO | NANOBIOTIX | N/A | 1.39B | ||
| PHARM | PHARMING GROUP NV | 47.29 | 1.011B | ||
| DBV | DBV TECHNOLOGIES SA | N/A | 1.01B | ||
| PHGN | PHARMING GROUP NV | 47.13 | 1.008B | ||
| DBV | DBV TECHNOLOGIES SA | N/A | 954.74M | ||
| IVA | INVENTIVA SA | N/A | 895.23M |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Milan Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About 1SRPT.MI
Company Profile
The company is headquartered in Cambridge, Massachusetts and currently employs 835 full-time employees.
Company Info
IPO: 1997-06-04
SAREPTA THERAPEUTICS INC
215 First Street, Suite 415
Cambridge MASSACHUSETTS US
Employees: 835
Phone: 16172744000
SAREPTA THERAPEUTICS INC / 1SRPT.MI FAQ
What does 1SRPT do?
The company is headquartered in Cambridge, Massachusetts and currently employs 835 full-time employees.
Can you provide the latest stock price for SAREPTA THERAPEUTICS INC?
The current stock price of 1SRPT.MI is 18.9 EUR. The price decreased by -3.47% in the last trading session.
Does 1SRPT stock pay dividends?
1SRPT.MI does not pay a dividend.
How is the ChartMill rating for SAREPTA THERAPEUTICS INC?
1SRPT.MI has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What is the next earnings date for 1SRPT stock?
SAREPTA THERAPEUTICS INC (1SRPT.MI) will report earnings on 2026-05-06, after the market close.
Can you provide the ownership details for 1SRPT stock?
You can find the ownership structure of SAREPTA THERAPEUTICS INC (1SRPT.MI) on the Ownership tab.